Figure 6.

CELF2 expression is downregulated in multiple cancers and associated with poor clinical outcomes. (A and B) The expression level of CELF2 mRNA in BRCA, LGG and GBM from the TCGA sample set is compared between primary tumors and solid normal tissues. Kaplan–Meier survival curves relative to CELF2 expression were estimated between the upper and lower quartiles in (C) BRCA and (D) LGG sample sets. (E) Kaplan–Meier plot for GBM patients with copy number loss of the CELF2 gene compared to wild type.